Notify me when Scilex Holding Co files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| DNQAF | Semnur Pharmaceuticals, Inc. | Common Stock, par value $0.0001 | 82% | 188,554,849 | Scilex Holding Company | 22 Sep 2025 | |||
| DVLT | DATAVAULT AI INC. | Common Stock, par value $0.0001 per share | 37% | $139,396,958 | -$10,411,129 | 213,766,229 | -6.9% | Scilex Holding Company | 12 Jan 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|